Clinical and biochemical correlates of insoluble α-synuclein in dementia with Lewy bodies

By Klucken Jochen   Ingelsson Martin   Shin Youngah   Irizarry Michael   Hedley-Whyte E.   Frosch Matthew   Growdon John   McLean Pamela   Hyman Bradley  

Acta Neuropathologica, Vol. 111, Iss. 2, 2006-02 ,pp. : 101-108

Springer Publishing Company

Access to resources Recommend Favorite

Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

By Paleologou Katerina E.  

Brain, Vol. 132, Iss. 4, 2009-04 ,pp. : 1093-1101

Oxford University Press

Access to resources Recommend Favorite

Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease

By Yokota Osamu   Davidson Yvonne   Arai Tetsuaki   Hasegawa Masato   Akiyama Haruhiko   Ishizu Hideki   Terada Seishi   Sikkink Stephen   Pickering-Brown Stuart   Mann David  

Acta Neuropathologica, Vol. 120, Iss. 6, 2010-12 ,pp. : 789-801

Springer Publishing Company

Access to resources Recommend Favorite

The role of α-synuclein assembly and metabolism in the pathogenesis of Lewy body disease

By Hashimoto Makoto   Kawahara Kohichi   Bar-On Pazit   Rockenstein Edward   Crews Leslie   Masliah Eliezer  

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 343-352

Humana Press, Inc

Access to resources Recommend Favorite

Multiplication of the α-synuclein gene is not a common disease mechanism in Lewy body disease

By Lockhart Paul   Kachergus Jennifer   Lincoln Sarah   Hulihan Mary   Bisceglio Gina   Thomas Natalie   Dickson Dennis   Farrer Matthew  

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 337-341

Humana Press, Inc

Access to resources Recommend Favorite